Indeed, a differential expression analysis using TCGA data finds DYRK1B to be overexpressed in several tumor types, including bladder (BLCA); breast (BRCA); kidney (KICH, KIRC and KIRP); liver (LIHC); prostate (PRAD); thyroid (THCA) and uterus (UCEC) (Table S1). This evidence concerns the gene DYRK1B and neoplasm.